Evidence map›Paper›PMID 36418559›Full record

ArticleJournal of cancer research and clinical oncology2023

Sperm and testicular tissue cryopreservation and assisted reproductive technology outcomes in male cancer patients: a 15-year experience.

Marta J Fernández-González, Anne-Catherine Radauer-Plank, Cornelia Stelzer, Waldemar Geiger, Irena Goranova, Anja Borgmann-Staudt, Magdalena Balcerek, Ina Wilkemeyer

Abstract read
In one paragraph

Article in Journal of cancer research and clinical oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Utilization of sperm cryopreservation in patients with testicular cancer.Journal of cancer research and clinical oncology · 2024
    Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Marta J Fernández-GonzálezDepartment of Pediatric Oncology and Hematology, Charité-Universitätsmedizin Berlin, Cooperation Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Anne-Catherine Radauer-PlankDepartment of Pediatric Oncology and Hematology, Charité-Universitätsmedizin Berlin, Cooperation Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Cornelia StelzerClinic for Urology-Cryobank, Charité-Universitätsmedizin Berlin, Cooperation Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Waldemar GeigerClinic for Urology-Cryobank, Charité-Universitätsmedizin Berlin, Cooperation Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Irena GoranovaClinic for Urology-Cryobank, Charité-Universitätsmedizin Berlin, Cooperation Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Anja Borgmann-StaudtDepartment of Pediatric Oncology and Hematology, Charité-Universitätsmedizin Berlin, Cooperation Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Magdalena Balcerek *Department of Pediatric Oncology and Hematology, Charité-Universitätsmedizin Berlin, Cooperation Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Ina Wilkemeyer *Clinic for Urology-Cryobank, Charité-Universitätsmedizin Berlin, Cooperation Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany. ina.wilkemeyer@charite.de.

Funding

Stiftung für urologische Forschung Stiftung für urologische Forschung
6 · The paper itself

Abstract

objectiveTo explore the characteristics of cancer patients who cryopreserved sperm/testicular tissue samples in the Cryobank of Charité-Universitätsmedizin Berlin between 2004 and 2019, and the ART utilization rate with associated outcomes.

methodsRetrospective data were available for 506 cancer patients, of which 46 (9.1%) had used their samples for artificial reproductive technologies (ART). Corresponding cycle information was collected from external fertility centers.

resultsOur cohort included 53/506 (10.5%) patients aged < 18 years at diagnosis. While adolescents and adults mainly banked sperm, adolescents showed higher rates of testicular tissue cryopreservation before (11.8%, 6/51 vs. 6.4%, 26/406) and after treatment (16.7%, 4/24 vs. 7.8%, 13/167). At study conduction, storage had been ended for 44.8% (269/601) of samples. The majority of samples used for ART were requested within the first 3 years after cryopreservation (71.5%, 28/39, range = 0-12 years). Pregnancy rate was 51.4% (19/37 cycles), resulting in 11 singleton births, 3 twin pairs, and 4 miscarriages.

conclusionWith the new advantage of public health insurance coverage of fertility preservation (FP) in Germany, an increased utilization has already been noticed in our center, emphasizing the necessity of further knowledge for individual counseling. Adolescent cancer patients need to be addressed specifically, as these patients show especially low cryopreservation rates.

Indexed as

NeoplasmsSemenAdolescentAdultCryopreservationFemaleHumansMalePregnancyReproductive Techniques, AssistedRetrospective StudiesSpermatozoaAdolescentsAssisted reproduction technologyCancerFertility preservationMale

Identifiers

PMID36418559
PMCPMC10349735

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.